Financhill
Back

uniQure NV Vs. Pharming Group Industry Stock Comparison

Sell
23

QURE
uniQure NV

Last Price:
5.78
Seasonality Move:
10.46%
Sell
42

PHAR
Pharming Group

Last Price:
7.48
Seasonality Move:
13.41%
Sell
23
uniQure NV (QURE) is a Sell

Is uniQure NV a Buy, Sell or Hold?

  • The current uniQure NV [QURE] share price is $5.85. The Score for QURE is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • QURE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Pharming Group (PHAR) is a Sell

Is Pharming Group a Buy, Sell or Hold?

  • The current Pharming Group [PHAR] share price is $7.76. The Score for PHAR is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • PHAR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

QURE Stock Price Chart

What is uniQure NV's stock price today?

  • The uniQure NV share price today is $5.85
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and QURE is experiencing buying pressure, which is a positive indicator for future bullish movement.

PHAR Stock Price Chart

What is Pharming Group's stock price today?

  • The Pharming Group share price today is $7.76
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PHAR is experiencing buying pressure, which is a positive indicator for future bullish movement.

QURE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 43.86 Sell
Chaikin Money Flow: 435453 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (5.89 - 7.05) Sell
Bollinger Bands (100): (5.16 - 7.62) Sell

PHAR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.19 Sell
Relative Strength Index (14 RSI): 42.78 Sell
Chaikin Money Flow: 10574 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.88 - 8.8) Sell
Bollinger Bands (100): (7.59 - 8.61) Sell

QURE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.25 Sell
20-day SMA: 6.46 Sell
50-day SMA: 5.92 Sell
200-day SMA: 5.75 Buy
8-day EMA: 6.17 Sell
20-day EMA: 6.32 Sell
50-day EMA: 6.18 Sell
200-day EMA: 6.48 Sell

PHAR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.86 Sell
20-day SMA: 8.21 Sell
50-day SMA: 8.25 Sell
200-day SMA: 9.11 Sell
8-day EMA: 7.85 Sell
20-day EMA: 8.09 Sell
50-day EMA: 8.19 Sell
200-day EMA: 9.02 Sell

uniQure NV Earnings Growth & QURE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.34 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.34 per share, and an increase next year of $0.99 per share.

Pharming Group Earnings Growth & PHAR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.01 per share, and an increase next year of $0.03 per share.

uniQure NV Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Pharming Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):